Senior insider sale
Exec. VP and CLO at PTC THERAPEUTICS, INC. — senior position signals high conviction
$1.47M
19.14K shares
What this filing means
BOULDING MARK ELLIOTT plans to sell 19.14K shares of PTC THERAPEUTICS, INC. valued at approximately $1.47M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/17/2026ACC: 0001959173-26-004755
Officer· Exec. VP and CLO
Since Jan 2019
19.14K
Shares to sell
$1.47M
Approx. market value
10.52K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
6/17/2026
10.52KTotal acquired10.52K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/17/2026 | Stock Option Exercise Cash | 10.52K | — |
| Total | 10.52K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
2.81K
Market value
$203.0K
5/15/2026
—Completed
Units to sell
3.54K
Market value
$279.6K
5/8/2026
—Completed
Units to sell
2.27K
Market value
$157.3K
4/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10.52K
Market value
$827.6K
6/17/2026
Total
Units
19.14K
Value
$1.47M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/15/2026 | 2.81K | $203.0K | — | Completed |
5/8/2026 | 3.54K | $279.6K | — | Completed |
4/6/2026 | 2.27K | $157.3K | — | Completed |
| Planned — Approximate Date | ||||
6/17/2026 | 10.52K | $827.6K | NASDAQ | Planned |
| Total | 19.14K | $1.47M | ||